QUALIGEN THERAPEUTICS INC (QLGN)

US74754R2022 - Common Stock

4.51  -0.03 (-0.66%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.004.98M5.65M2.85M
Minority Interest Expense
N/AN/A2.39MN/AN/A
Cost Of Goods
N/AN/A4.30M4.33M2.64M
Gross Profit
N/AN/A680.00K1.32M210.00K
Operating Expenses
6.71M11.30M18.62M23.99M10.73M
Research and Development
2.55M5.21M6.84M11.72M3.32M
Selling, General, and Administrative Expenses
4.15M6.10M11.79M12.27M7.41M
Operating Income
-6.71M-11.30M-17.94M-22.66M-10.52M
Interest Income/Expense
-843.93K-1.52M-30.00K40.00K-50.00K
Other Income/Expense
699.56K2.07M910.00K4.73M-8.05M
Non Recurring Items
-927.92K-1.70M-4.24MN/A-920.00K
Income Before Taxes
-7.78M-12.48M-21.30M-17.89M-19.55M
Income Tax
-6.41K-4.79K-270.00K10.00K0.00
Net Income
-7.94M-13.42M-18.64M-17.90M-19.55M
EBITDA
N/A-11.30M-17.79M-22.55M-10.43M
 
Per Share Data
EPS Diluted Total Ops
-56.10-132.25-4.85-6.10-11.23
Non GAAP EPS
N/AN/AN/A-6.10N/A
 
Statistics
Gross Profit Margin
N/AN/A13.65%23.36%7.37%
Profit Margin
N/AN/A-374.30%-316.81%-685.96%
Operating Profit Margin
N/AN/A-360.24%-401.06%-369.12%

All data in USD

Charts